Comparing the Renoprotective Effects of BM-MSCs versus BM-MSC-Exosomes, When Combined with an Anti-Fibrotic Drug, in Hypertensive Mice

Scientists determined whether serelaxin (RLX) could enhance the therapeutic efficacy of bone-marrow-derived- mesecnymal stem cell-exosomes (BM-MSC-EXO), and compared the renoprotective effects of RLX and BM-MSC-EXO versus RLX and BM-MSCs in mice with hypertensive CKD.